Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 1, 1997, Pages 73-76

  Kobayashi, Masakazu ^a   Tanaka, Eiji ^a   Matsumoto, Akihiro ^a   Ichijo, Tetsuya ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronicity; Hepatitis C virus genotype; Neutralizing antibody; Post transfusion hepatitis

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031038554     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00350.x     Document Type: Article

References (18)

1. Kuo G, Choo Q-L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
2. Kato N, Sekiya H, Ootsuyama Y et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 1993; 67: 3923-30.
3. Chien DY, Choo Q-L, Tabrizi A et al. Diagnosis of hepatitis C virus (HCV) infection using an immuno-dominant chimeric polyprotein to capture circulating antibodies: Re-evaluation of the role of HCV in liver disease. Proc. Natl Acad. Sci. USA 1992; 89: 10 011-15.
4. Lok AS, Chien D, Choo Q-L et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immuno-suppressed patients. Hepatology 1993; 18: 497-502.
5. Weiner AJ, Mario Geyson H, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc. Nad Acad. Sci. USA 1991; 89: 3468-72.
6. Taniguchi S, Okamoto H, Sakamoto M et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology 1993; 195: 297-301.
7. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 1994; 68: 1494-500.
8. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N. Engl. J. Med. 1989; 321: 1494-500.
9. Tanaka E, Kiyosawa K, Nakatsuji Y et al. Clinical significance of antibody to nonstructural and core proteins of hepatitis C virus in post-transfusion hepatitis patients during long-term follow-up. J. Med. Virol. 1993; 39: 318-24.
10. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 1994; 39: 1273-80.
11. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
12. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
13. Lesniewski R, Okasinski R, Carrick C et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. J. Med. Virol. 1995; 45: 415-22.
14. Choo Q-L, Kuo G, Ralston R et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl Acad. Sci. USA 1994; 91: 1294-8.
15. Yamaguchi K, E Tanaka, Higashi K et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 1344-8.
16. Diepolder HM, Zachoval RZ, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-7.
17. Prati D, Capelli C, Zanella A et al. Influence of different hepatitis C virus genotype on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110: 178-83.
18. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis c: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-9.